Clinical TrialsSearch results
Number of results: 916
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Single-center, open-label, single-arm study study to investigate efficacy and safety of Hydroxychloroquine in ATLL patients
- Adult T-Cell Leukemia-Lymphoma
- Amano Masahiro
- 2023-01-26
Other
- Japanese Research of Cholesterol and Diabetes Mellitus
- Diabetics and the patients with impaired glucose tolerance
- AMED
- 2006-11-10
Recruiting
- AADHERE Study
- obstructive sleep apnea syndrome
- Ando Shin-ichi
- 2022-01-31
Completed
- Cooperative development of hemodynamic monitor including cardiac output based on the measurement of lung-finger circulation time.
- ex.1) heart failure (including pre-heart failure subjects) ex.2) healthy subjects
- Ando Shin-ichi
- 2018-09-03
Other
- A PHASE II, RANDOMIZED, ACTIVE-CONTROLLED, MULTI-CENTER STUDY COMPARING THE EFFICACY AND SAFETY OF TARGETED THERAPY OR CANCER IMMUNOTHERAPY GUIDED BY GENOMIC PROFILING VERSUS PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH CANCER OF UNKNOWN PRIMARY SITE WHO HAVE RECEIVED THREE CYCLES OF PLATINUM DOUBLET CHEMOTHERAPY
- CANCER OF UNKNOWN PRIMARY
- Andreas Beringer
- 2021-01-15
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04
Other
- The renoprotective effects of ARB in patients with IgA nephropathy : multicenter,radomized trial
- IgA nephropathy
- ARB therapeutic society of IgA nephropathy
- 2006-03-31
Completed
- Phase I/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients with Retinopathy of Prematurity
- Retinopathy of Prematurity
- Arima Mitsuru
- 2020-10-28
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Phase III clinical trial for AT-877 (i.v.) in patients with acute ischemic stroke. Placebo-controlled, double-blind add-on therapy to antiplatelet drugs
- Acute ischemic stroke (excluding cardioembolic stroke)
- Asahi Kasei Pharma Corporation
- 2007-07-02